| Literature DB >> 27378473 |
Elgerta Ismaili1,2, Sally Walsh3, Patrick Michael Shaughn O'Brien4, Torbjorn Bäckström5, Candace Brown6,7, Lorraine Dennerstein8, Elias Eriksson9, Ellen W Freeman10,11, Khaled M K Ismail12, Nicholas Panay13, Teri Pearlstein14, Andrea Rapkin15, Meir Steiner16,17, John Studd18, Inger Sundström-Paromma19, Jean Endicott20, C Neill Epperson21,22, Uriel Halbreich23, Robert Reid24, David Rubinow25, Peter Schmidt26, Kimberley Yonkers21,22.
Abstract
Whilst professional bodies such as the Royal College and the American College of Obstetricians and Gynecologists have well-established standards for audit of management for most gynaecology disorders, such standards for premenstrual disorders (PMDs) have yet to be developed. The International Society of Premenstrual Disorders (ISPMD) has already published three consensus papers on PMDs covering areas that include definition, classification/quantification, clinical trial design and management (American College Obstetricians and Gynecologists 2011; Brown et al. in Cochrane Database Syst Rev 2:CD001396, 2009; Dickerson et al. in Am Fam Physician 67(8):1743-1752, 2003). In this fourth consensus of ISPMD, we aim to create a set of auditable standards for the clinical management of PMDs. All members of the original ISPMD consensus group were invited to submit one or more auditable standards to be eligible in the inclusion of the consensus. Ninety-five percent of members (18/19) responded with at least one auditable standard. A total of 66 auditable standards were received, which were returned to all group members who then ranked the standards in order of priority, before the results were collated. Proposed standards related to the diagnosis of PMDs identified the importance of obtaining an accurate history, that a symptom diary should be kept for 2 months prior to diagnosis and that symptom reporting demonstrates symptoms in the premenstrual phase of the menstrual cycle and relieved by menstruation. Regarding treatment, the most important standards were the use of selective serotonin reuptake inhibitors (SSRIs) as a first line treatment, an evidence-based approach to treatment and that SSRI side effects are properly explained to patients. A set of comprehensive standards to be used in the diagnosis and treatment of PMD has been established, for which PMD management can be audited against for standardised and improved care.Entities:
Keywords: PMD (premenstrual disorder); PMDD (premenstrual disorder/premenstrual dysphoric disorder); PMS (premenstrual syndrome)
Mesh:
Year: 2016 PMID: 27378473 DOI: 10.1007/s00737-016-0631-7
Source DB: PubMed Journal: Arch Womens Ment Health ISSN: 1434-1816 Impact factor: 3.633